Endophytic fungi: a reservoir of antibacterials

Sunil K Deshmukh1, Shilpa A Verekar1, Sarita V Bhave1

  • 1Department of Natural Products, Piramal Enterprises Limited Mumbai, India.

Frontiers in Microbiology
|January 27, 2015
PubMed

Insights

Multidrug-resistant bacteria pose a growing global threat, especially in developing nations. Exploring natural sources like endophytic fungi and traditional medicines may yield novel, affordable antibiotic scaffolds.

Area of Science:

  • Microbiology
  • Pharmacology
  • Natural Product Chemistry

Background:

  • Rising prevalence of multidrug-resistant (MDR) bacteria globally.
  • Specific MDR pathogens include Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococcus faecium (VRE), Penicillin-resistant Streptococcus pneumoniae, and MDR Mycobacterium tuberculosis.
  • Urgent need for novel antimicrobial agents to combat resistance.

Purpose of the Study:

  • To review the potential of natural products, particularly endophytic fungi, as sources for new antibiotic scaffolds.
  • To highlight the challenge of developing effective and affordable antimicrobial drugs.
  • To explore the relevance of traditional indigenous therapeutics, such as Ayurveda, in the Asian subcontinent.

Main Methods:

  • Literature review of studies on MDR bacteria.
  • Review of research on endophytic fungi as a source of bioactive compounds.
  • Examination of traditional medicine systems for antimicrobial leads.

Main Results:

  • Endophytic fungi represent a promising reservoir for novel therapeutic compounds.
  • Development of new, specific, and affordable antibiotics is a significant global challenge.
  • Indigenous therapeutics may offer valuable leads requiring further scientific investigation.

Conclusions:

  • Natural product discovery, especially from endophytic fungi, is crucial for addressing antibiotic resistance.
  • Further in-depth research into traditional medicine systems could uncover effective antimicrobial strategies.
  • A multidisciplinary approach is needed to develop affordable and effective solutions for MDR infections.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
103
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
198
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
2.1K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
767
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
90
Overview of Fungi01:29

Overview of Fungi

Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
2.6K